GoToHealth Media Video

Empowering patients to monitor their multiple sclerosis symptoms and neurologic function from home – Charisse Litchman, MD

Patient access to their physicians is a primary mover for healthcare improvement in 2020’s.  One of the ways to enable close connection and communication is through easily useable mobile phone apps which allow patient input and secure data sharing with a chosen doctor’s office.

By playing games on your phone and answering questions about how you feel, the BeCare app can generate objective measurements of changes in your neurologic function, your cognition and your mood. It captures data about what meds you have been on and the benefit you experienced, the frequency and nature of your MS flares, your mood, your diet and exercise and your family history. The data is linked to the computer of any physician you select, and your physician can use the information to modify your treatment as appropriate.

In this presentation, Dr. Charisse Litchman discusses their award-winning app for patients managing their multiple sclerosis symptoms, and how it helps both patients and their health professionals monitor progress and adjust treatments.

 

Did you like this?

Please leave us a Testimonial.

Your words help us get the word out.
Thanks for your feedback!!

About Your Presenter

Chief Medical Officer (CMO) at | cdlitchman@becare.net | Website | + more

Charisse Litchman, MD is a neurologist who trained at Yale School of Medicine and Cornell-New York Hospital. She had a private practice for 25 years before joining the faculty at Yale School of Medicine. She has worked with a Contract Research Organization monitoring pharmaceutical trials and created a migraine service at a Telehealth company. Dr. Litchman is the Chief Medical Officer at BeCare MS. BeCare is a digital health company specializing in neurologic disorders such as Multiple Sclerosis. BeCare's goal is to empower patients to help their physicians follow their clinical progress as well as to help facilitate pharmaceutical trials in advancing the care of MS patients.

No tags for this post.

Related Posts

%d bloggers like this: